This webinar was recorded on 08/25/2026. No CEUs are provided for recorded events.
This webinar offers an overview of the recent rescheduling of medical cannabis from a Schedule I to Schedule III substance. Attendees will learn about the difference between Schedule I and Schedule III substances, what the policy change means for people who use medical cannabis, the potential impact of rescheduling on cannabis retailers, and the potential for researchers to study cannabis with fewer DEA requirements. Attendees will also learn about the practical challenges and legal uncertainties that result from persistent tensions between federal and state laws and regulations.